Fact check: Kennedy repeats false and misleading claims in confirmation hearing
In his first Senate confirmation hearing to be secretary of the Department of Health and Human Services, Robert F. Kennedy Jr ...
Which Foods Contain Red Dye 3? What To Be Aware Of After FDA Ban, Per Food Safety Expert
Just a few weeks ago on January 15, the Food and Drug Administration (FDA) under the Biden administration revoked authorization of the additive red dye 3, meaning it will be banned from foods and ...
phillyvoice.com2d
A new blood test accurately screens for colorectal cancer, researchers say
Research that has not yet been peer-reviewed shows the newest blood test is more than 80% accurate in detecting colon cancer ...
Futurism on MSN2d
Trump Administration Throws Cancer Research Into Turmoil
During Donald Trump's draconian first-week rollbacks, cancer research and other crucial medical projects have been paused ...
Interesting Engineering on MSN8h
Sniffing out cancer: Scientists test nasal drug for deadly pancreatic tumors
A groundbreaking approach led by a team of scientists, including Rice University chemist James Tour, has the potential to ...
STAT11d
AstraZeneca, Daiichi Sankyo win first U.S. approval for key cancer drug
A drug from AstraZeneca and Daiichi Sankyo won authorization for a form of breast cancer, the first U.S. approval for the ...
PBS5d
The FDA banned Red 3 food coloring. A scientist explains the dye’s history and health risks
Over 35 years after the first study linking the artificial food dye Red 3 to thyroid cancer in rats was published, the U.S.
As Trump and RFK Jr. move to upend drug making, Seattle biotech bets on science
Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...
A grim prognosis, a gamble and one patient’s fight to defy cancer
After a Stage 4 cancer diagnosis and a prognosis of 16 months to live, Katie Doble didn’t know whether she should plan her ...
Daiichi Sankyo Shares Jump After U.S. FDA Approves Breast Cancer Drug
Daiichi Sankyo shares rose sharply after the U.S. Food and Drug Administration approved its breast cancer drug Datroway. Shares were recently 8.7% higher at 4,437 yen, equivalent to $28.39, on Monday ...
Cure Today3d
FDA Approves Enhertu for HER2-Low and -Ultralow Breast Cancer
The antibody drug conjugate was approved for patients with unresectable or metastatic HER2-low or -ultralow breast cancer ...
EurekAlert!1d
‘Pushing the boundaries of radiation treatment’: Breakthrough in pancreatic cancer therapy advances to clinical trials
A novel approach developed by scientists, including Rice University chemist James Tour, could transform treatment for ...